The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Teva Pharmaceuticals will pay $420 million in a federal case
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Sol Barer elected chairman of Israel's Teva Pharmaceuticals - NJBIZ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
A Look At Kare Schultz, The New CEO In Charge Of Teva
Teva Pharmaceuticals - Wikipedia
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO | InvestorPlace
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva Pharmaceuticals (@TevaUSA) / Twitter
DEF 14A
Teva's new CEO shakes up management, to combine divisions | Reuters
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva Shareholders Criticize Generics CEO Switch | CHEManager
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Five Things Facing Teva's New CEO Richard Francis :: Generics Bulletin
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
End Of Schultz Era Looms For Teva :: Generics Bulletin
Teva Pharmaceutical Stock Could Double | Barron's
Teva Time Capsule - Our History - YouTube
Teva Pharmaceuticals (@TevaUSA) / Twitter
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
